An NCI-designated Comprehensive Cancer Center
Weitzel 256x256
$8.5M grant fuels research into rare genetic disorder
January 10, 2020 | by Letisia Marquez
The National Institutes of Health funding will support a City of Hope study of a rare cancer-causing syndrome linked to an inherited mutation in the TP53 gene. Li-Fraumeni syndrome causes various cancers early in life.
Clinical Trials/Studies
brain tumor
New immunotherapy trial targets recurrent glioblastoma
January 10, 2020 | by Letisia Marquez
City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma. To launch the randomized trial, the National Institutes of Health awarded $3.3 million over five years to Behnam Badie, M.D. and Christine Brown, Ph.D. Brown and Badie also received $800,000 from Gateway for Cancer Research.
Clinical Trials/Studies
Chen Receives $3.3M Grant
for Prostate Mushroom Study
January 9, 2020 | by C. Pete Lee
Shiuan Chen, Ph.D., who heads City of Hope’s Natural Therapies Program, is studying the effects of white button mushrooms on prostate cancer patients. He previously found that phytochemicals in mushrooms had the ability to block the activity of an enzyme that contributes to breast cancer.
Clinical Trials/Studies
Microbes in Space | City of Hope
Can terrestrial microbes survive in outer space? City of Hope and NASA team up to find out
January 9, 2020 | by Maxine Nunes
Can terrestrial microbes survive in outer space — and if so, how do they do it? These are some of the questions that researchers at City of Hope, working with NASA’s Jet Propulsion Laboratory, set out to answer. Their discoveries are shedding new light on a range of subjects from human health to the origins of life on Earth.
Faculty | Clinical Trials/Studies
T cell therapy
New Immunotherapy Research Presented at ASH
January 9, 2020 | by Letisia Marquez
City of Hope physicians and scientists discussed clinical trials that provide the foundation for new treatments for patients with leukemia, lymphoma and multiple myeloma. They also discussed preclinical studies on a new target for acute myeloid leukemia.
Faculty | Clinical Trials/Studies
molecule 256x256
Core Connection: Drug Discovery and Structural Biology Core
January 7, 2020 | by Katie Neith
At City of Hope, the Drug Discovery and Structural Biology (DDSB) Core exists to help speed the translation of basic science discoveries into the clinic.